Metadate ER is commonly prescribed to treat narcolepsy and attention deficit hyperactivity disorder. By affecting certain chemicals in the brain to produce a calming effect, it is effective in treating ADHD symptoms in children. When taken in higher doses, the medicine works as a stimulant to help people with narcolepsy stay awake during the day. Common side effects include headache, nausea, and dizziness.
Metadate ER® (methylphenidate extended-release) is a prescription medication used to treat attention deficit hyperactivity disorder (ADHD). It is also used to treat narcolepsy.
Because the drug is a stimulant and is commonly abused, there are special rules for prescribing it (see Metadate Abuse and Metadate: A Controlled Substance for more information).
Metadate ER is manufactured by UCB, Inc. A generic version of the drug is made by several different manufacturers.
As mentioned, the drug is licensed to treat ADHD. In addition to hyperactivity (having trouble sitting still), people with ADHD have problems paying attention, focusing, and controlling their behavior. While most people think of ADHD as a problem in children, it can also occur in adults (see Adult ADHD). However, Metadate ER is not approved for use in adults (see Metadate and Adults).
Metadate ER is also licensed for the treatment of narcolepsy. This is a condition that involves falling asleep uncontrollably and at unusual times. People who have this condition often appear paralyzed when they are asleep and have hallucinations when falling asleep. They also often fall asleep several times during the day.
(Click Metadate ER Uses for more information on this topic, including possible off-label uses for the drug.)